Interview with Trevor Mundel on COVID-19. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The…
Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team.
Interview with Valerie Nkamgang Bemo on COVID-19. Bemo manages the Bill & Melinda Gates Foundation’s investments that support communities affected by natural disasters and complex emergencies.
For many women in Niger, basic knowledge about how to keep themselves and their families healthy is out of reach. Malama Ouani, a Muslim cleric in Maradi, Niger, discusses the…
Gates Foundation CEO, Dr. Sue Desmond-Hellmann, reflects on the progress we’ve made and the setbacks and frustrations she’s experienced in her first five years at the foundation.
The Optimist sat down with Damian Walker, deputy director of data and analytics at the Gates Foundation, to talk about how the team approached evaluating the return on a $10…
This is the number-one question I get from our partners in government, academia, and the private sector. I’ll start by repeating two key principles of the Gates Foundation, because they…
“We are awed by our friend Warren Buffett’s decision to use his fortune to address the world’s most challenging inequities, and we are humbled that he has chosen to direct…
